➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Mallinckrodt
AstraZeneca
McKinsey
Dow

Last Updated: December 3, 2020

DrugPatentWatch Database Preview

Litigation Details for Shire LLC v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2011)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Shire LLC v. Mylan Pharmaceuticals Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Shire LLC v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2011)

Date Filed Document No. Description Snippet Link To Document
2013-01-14 173 specifically U.S. Patent Nos. 6,287,599 (“the ‘599 patent”), and 6,811,794 (“the ‘794 patent”) (collectively…CONSTRUING PATENT CLAIMS This patent infringement case involves two United States Patents issued…formulation patents directed to these new dosages. In response, Shire filed the second patent infringement…both the ‘599 and the ‘794 patents should have the same meaning in each patent. Prior to the Markman hearing…appears in Claim 2 of the ‘599 patent and Claims 4 and 9 of the ‘794 patent; and (2) the term “about,” External link to document
2011-04-20 3 for infringement of U.S. Patent Nos. 6,287,599 B1 ("the '599 patent") and 6,811,794 B2 …expiration of the '599 patent and the '794 patent (collectively, "the patents-in-suit"). …;794 patent") (Exhibit A and Exhibit B, respectively). This action is based upon the Patent Laws… THE PATENTS-IN-SUIT 11. On September 11, 2001, the '599 patent, entitled…owner of the '599 patent. Shire has an exclusive license under the '599 patent with regard to pharmaceutical External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
AstraZeneca
Boehringer Ingelheim
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.